NCT06666751
Anterior Segment Optical Coherence Tomography Microstent Positioning
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 2 words Show 4 more changesShow less
- Trial completed
- Final enrollment: 79 participants (planned 116)
- Primary completion date changed from estimate of Apr 30, 2027 to Oct 16, 2025
- Secondary endpoints: 6 to 5
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Difference in percentage of mispositioned stents between Hydrus microstent and iStent groups
Timeframe: Two years post stent placement
Secondary (5)
Dilation of Schlemm's canal
Change in IOP from baseline
Reduction in number of IOP lowering medications
Percentage of patients needing additional glaucoma surgery
Proportion of stent cases with proper placement via anterior segment OCT versus proportion of cases with proper placement via intraoperative gonioscopy
Arms and interventions
Hydrus microstent
Participants in this group underwent Hydrus microstent placement at the Moran Eye Center.
iStent Inject
Participants in this group underwent iStent Inject placement at the Moran Eye Center.
Procedures: Cataract plus Microstent surgery
Sites
1 site in 1 country
- Moran Eye CenterMurray, Utah, United States